Comprehensive COPD self-management program,
does it really help with Reduced COPD-related hospitalization?
research showsThe grade is D. In 426 patients, one-year cumulative COPD hospitalization was 27% versus 24%, HR 1.13 (95% CI 0.70-1.80). Deaths were 28/209 versus 10/217, HR 3.00 (1.46-6.17), and the trial stopped early for safety.
ads claimCOPD education remains part of care, but this specific package should not be sold as proven hospitalization prevention.
Useful facts when choosing a product
- The package combined five education sessions, an action plan, and scheduled case management.
- The registered and published primary outcomes matched.
- Funding came from the US Department of Veterans Affairs Cooperative Studies Program.
What the research actually shows
The intervention comprised four individual sessions, one group session, an exacerbation action plan, and proactive scheduled calls. Control was guideline-based usual care plus an information booklet. Allocation-concealment implementation and evidence that participant masking held were not reported in the publicly checked text.
Why this is classified as D (34)
A null primary outcome, prespecified mortality harm, and early termination give D with 34 points.
Counterpoint. The cause of excess mortality remained unexplained and does not indict all COPD education.
Rejudgment record. Cross-check applied — Null registered primary hospitalization outcome, prespecified mortality increase, and safety stopping
| Endpoint | H | Hard endpoint - actual events such as death |
| Replication | R1 | Single confirmatory trial |
| Independence | I2 | Decisive evidence is publicly or non-profit funded |
| Effect size | E- | Harm increased in the trials |
| Precision | C0 | The confidence interval leaves room for benefit |
The scoring table and the verdict agree (D).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Reduced COPD-related hospitalization | D | The result was null: 27% versus 24%, HR 1.13. |
| All-cause mortality safety | D | Mortality increased significantly, 28 versus 10. |
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Study 1 | 20-site VA randomized controlled trial stopped early for safety | 44 | Department of Veterans Affairs Cooperative Studies Program | Primary: time to first COPD hospitalization; secondary: all-cause mortality | Hospitalization 27% vs 24%, HR 1.13 (0.70-1.80); deaths 28 vs 10, HR 3.00 (1.46-6.17); mean follow-up 250 days | Pivotal publicly funded trial |
Receipt — 2 References
All 2 cited sources were verified for existence at the original page (as of 2026-08-08).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-08 · Corrections: none
Cite this verdict
[Chamgap] Comprehensive COPD self-management program x reduced hospitalization — Evidence Grade D·34. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/energy/copd-comprehensive-self-management-hospitalization/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.